WHO & Gates Monkeypox Pandemic ‘Simulation’ March 2021

Moneypox the wise Monkey of the Munich Security Conference

Pandemic creates new billionaire every 30 hours — now a million people could fall into extreme poverty at same rate in 2022
https://www.oxfam.org/en/press-releases/pandemic-creates-new-billionaire-every-30-hours-now-million-people-could-fall

As Monkeypox Cases Spread, Report Shows Gates Foundation, WHO, Pharma Execs Took Part in Monkeypox Pandemic ‘Simulation’
The World Health Organization on Friday held an emergency meeting to discuss the outbreak of monkeypox after more than
100 cases were reported across 12 countries, as a report surfaced showing the Gates Foundation, WHO and Pharma execs in
March 2021 conducted a monkeypox pandemic “simulation.”
https://childrenshealthdefense.org/defender/monkeypox-gates-foundation-who-pharma-execs-monkeypox-pandemic-simulation/

Exercise Summary

Developed in consultation with technical and policy experts, the fictional exercise scenario portrayed a deadly, global pandemic involving an unusual strain of monkeypox virus that first emerged in the fictional nation of Brinia and spread globally over 18 months.
https://www.nti.org/analysis/articles/strengthening-global-systems-to-prevent-and-respond-to-high-consequence-biological-threats/

Ultimately, the exercise scenario revealed that the initial outbreak was
caused by a terrorist attack using a pathogen engineered in a laboratory with inadequate biosafety and biosecurity provisions and weak oversight. By the end of the exercise, the fictional pandemic resulted in more than three billion cases and 270 million fatalities worldwide.
https://www.nti.org/analysis/articles/strengthening-global-systems-to-prevent-and-respond-to-high-consequence-biological-threats/

In March 2021, NTI partnered with the Munich Security Conference to conduct a tabletop exercise on reducing
high-consequence biological threats. The exercise examined gaps in national and international biosecurity and
pandemic preparedness architectures—exploring opportunities to mprove prevention and response capabilities for high-consequence
biological events. Participants included 19 senior leaders and experts from across Africa, the Americas, Asia, and Europe with
decades of combined experience in public health, biotechnology industry, international security, and philanthropy.

This report, "Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats: Results from
the 2021 Tabletop Exercise Conducted in Partnership with the Munich Security Conference," written by Jaime M. Yassif, Ph.D.,
Kevin P. O’Prey, Ph.D., and Christopher R. Isaac, M.Sc., summarizes key findings from the exercise and offers actionable
recommendations for the international community.

The report launch on November 23, 2021 was chaired by NTI | bio Interim Vice President Dr. Margaret A. Hamburg and featured
remarks from Twist Biosciences CEO and Co-Founder Dr. Emily Leproust, and NTI | bio Senior Fellow Dr. Jaime Yassif.
https://youtu.be/SLQ5rz9xCl4

Nov 23, 2021
Report Launch: Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats
https://www.nti.org/events/report-launch-strengthening-global-systems-to-prevent-and-respond-to-high-consequence-biological-threats/

First Patient Injected With Experimental Cancer-Killing Virus in New Clinical Trial
23 MAY 2022

drug candidate, called CF33-hNIS (aka Vaxinia), is what's called an oncolytic virus, a genetically modified virus CF33-hNIS, the modified
pox virus works by entering cells and duplicating itself. Eventually, the infected
cell bursts, releasing thousands of new virus particles

the City of Hope cancer care and research center in Los Angeles, and Australia-based biotech company Imugene – now announcing that the
first clinical trial in human oncolytic viruses can stimulate the immune system to respond to and kill cancer, as well as stimulate the immune
system to be more responsive to other immunotherapies,"CF33-hNIS individuals will receive low doses of the experimental treatment via direct
injection or intravenously. produces human sodium iodide symporter (hNIS), a protein that enables researchers to image and monitor
viral replication, as wellby adding radioactive iodine.
https://www.sciencealert.com/first-patient-injected-with-experimental-cancer-killing-virus-in-new-clinical-trial

CF33

Our lead candidate is a chimeric vaccinia (pox) virus known as CF33, developed by Professor Yuman Fong, at the prestigious
City of Hope Comprehensive Cancer Center in Los Angeles, California.
https://www.imugene.com/oncolytic-virus

Call for an independent inquiry into the origin of the SARS-CoV-2 virus

The data available within the United States would explicitly include, but are not limited to, viral sequences gathered and held as part of
the PREDICT project and other funded programs, as well as sequencing data and laboratory notebooks from US laboratories. We call on
US government scientific agencies,
most notably the NIH, to support a full, independent, and transparent investigation of the origins of SARS-CoV-2. This should
take place, for example, within a tightly focused science-based bipartisan Congressional inquiry with full investigative powers, which
would be able to ask important questions—but avoid misguided witch-hunts governed more by politics than by science.
Essential US Investigations
The US intelligence community (IC) was tasked, in 2021 by President Joe Biden (4), with investigating the origin of the virus. In their
summary public statement, the IC writes that “all agencies assess that two hypotheses are plausible: natural exposure to an
infected animal and a laboratory-associated incident”

Fourth, the failure of NIH, one of the main funders of the US–China collaborative work, to facilitate the investigation into the origins of SARS-CoV-2 (4)
has fostered distrust regarding US biodefense research activities.Much of the work on SARS-like CoVs performed in Wuhan was part of an active and
highly collaborative US–China scientific research program funded by the US Government (NIH, Defense Threat Reduction Agency [DTRA], and US
Agency for International Development [USAID]), coordinated by researchers at EcoHealth Alliance (EHA), but involving researchers at several
other US institutions.EHA, the University of North Carolina (UNC), the University of California at Davis (UCD), the NIH, and the USAID. Under
a series of NIH grants and USAID contracts, EHA coordinated the collection of SARS-like bat CoVs from the field in southwest China and southeast Asia
https://www.pnas.org/doi/10.1073/pnas.2202769119

Make no mistake: these shots are massively dangerous. You truly take an enormous risk by getting injected with this modified
spike protein, in my opinion. It absolutely has associations with
prion-like illnesses with demonstrable amyloidygenic properties.

I don’t think there’s any doubt that these modified spike proteins are amyloidygenic, thus being one of the big reasons for the atypical numbers
and diversity of adverse event reports in VAERS, the Yellowcard and the EUDRA systems.
(I still think the lipid nanoparticles are bad news, as well.)
https://jessicar.substack.com/p/modified-spike-protein-rna-injection?s=w

Coronavirus traces found in March 2019 sewage sample, Spanish study shows
MADRID (Reuters) - Spanish virologists have found traces of the novel coronavirus in a sample of Barcelona waste
water collected in March 2019, nine months before the COVID-19 disease was identified in
China, the University of Barcelona said on Friday.
https://www.reuters.com/article/us-health-coronavirus-spain-science-idUSKBN23X2HQ

Coronavirus: Sewage samples show COVID-19 was in Italy in December, scientists claim
The research shows the presence of coronavirus in the north of the country over two weeks before China reported its first cases.
https://news.sky.com/story/coronavirus-sewage-samples-show-covid-19-was-in-italy-in-december-scientists-claim-12010558

'Plausible' evidence that Covid may have been circulating in Italy in October 2019
Researchers say findings are "interesting" but conclusive evidence of widespread early infection is still needed

Re-testing of blood samples has shown that coronavirus may have been circulating in Italy as early as October 2019, two months
before China alerted the world to the new disease, researchers have claimed.

The World Health Organization asked for further clarification from researchers at a cancer centre in Milan after they claimed last
November that samples from cancer patients showed Covid may have been circulating for several months in northern Italy - even
before the first cases were reported in China in November 2019.

“The results of this retesting suggest that what we previously reported in asymptomatic patients is a plausible signal of early
circulation of the virus in Italy,” Giovanni Apolone, one of the researchers, told the Financial Times
https://www.telegraph.co.uk/global-health/science-and-disease/plausible-evidence-covid-may-have-circulating-italy-october/

COVID-19 circulating in Italy as early as September 2019, scientists claim
Patients in a cancer trial were found to have developed coronavirus antibodies months before the first official case in China.

The World Health Organization says COVID-19 was unknown before the outbreak was first reported in Wuhan, in central
China, in December. A few months later, the first official cases were detected in Europe.

However, scientists in Italy say they have found evidence the virus was circulating much sooner by checking blood
samples of patients taking part in a cancer study.
https://news.sky.com/story/covid-19-circulating-in-italy-as-early-as-september-2019-scientists-claim-12133825

The Woman Who Made the UK a World-Beater in Genomics

Sharon Peacock:
As vaccines were introduced, we sequenced samples from people with vaccine failure. We were able to spot new variants and we were
able to categorize whether people had (hypothetical) variant A or variant B. That allowed the UK to have the capability to do some of the
key studies around the variants and their degree of transmissibility, their degree of immune evasion and their degree of lethality.

SF: What is the value of continued genomic testing if vaccines don’t prevent infection, as we have seen?
SP: We’ve known for some while that vaccinations don’t prevent infection.

TR: What role do you see for wastewater surveillance going forward?

SP: Wastewater sequencing was really useful for detecting variants emerging or circulating in populations at different levels. I think the
future of wastewater sequencing is such that you can actually use it at different scales —
at population level or at a community scale, in a school or hospital.

Of course, if you have a single case of a new variant, you’re unlikely to be able to detect that very easily, because of the scale of the
waste you have the effect of having to pick a needle out of a haystack. But I think the wastewater sequencing can be really powerful

https://www.washingtonpost.com/business/the-woman-who-made-the-uk-a-world-beater-in-genomics/2022/05/23/08547870-da56-11ec-bc35-a91d0a94923b_story.html

Concerns of Fraud in Pfizer Vaccine Trial as Participant’s Hospitalisation with Heart Inflammation is Swept Under Carpet
https://dailysceptic.org/2022/05/23/concerns-of-fraud-in-pfizer-vaccine-trial-as-participants-hospitalisation-with-heart-inflammation-is-swept-under-carpet/

22nd May is the start of the World Health Organisation’s 75th annual World Health Assembly, in Geneva. Funnily enough, that’s
the same day the World Economic Forum’s DAVOS summit begins over on the other side of Switzerland.

A coincidence, to be sure.
https://off-guardian.org/2022/05/20/the-who-is-changing-their-international-health-regulations-thats-not-good/

the Defense Threat Reduction Agency (DTRA) U.S. Department of Defense (DOD) Labyrinth Global Health INC. ‘Biological threat reduction program in Ukraine’.
Peter Daszak’s EcoHealth Alliance, and Ernest Wolfe’s Metabiota
Black & Veatch Special Projects Corp The leadership team of Labyrinth Global consists of Karen Saylors, PHD who is the Chief Executive Officer; Mary Guttieri,
PHS who is the Chief Science Officer; and Murat Tartan who is the Chief Financial Officer Dr Karen Saylors, Eco-Health Alliance and Metabiota worked together on the United States Agency for International Development (USAID) ‘PREDICT’ program from 2009, while Labyrinth Global Health worked alongside EHA and Metabiota on the PREDICT program from 2017.

Confidentiality agreement which can be viewed here, states that providers ‘Moderna’ alongside the ‘National Institute of Allergy and Infectious Diseases (NIAID) agreed to transfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna to recipients ‘The University of North Carolina at Chapel Hill’ on the 12th December 2019.

The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019

The agreement was also signed by two representatives of the NIAID, one of whom was Amy F. Petrik PhD, a technology transfer
specialist who signed the agreement on December 12th 2019 at 8:05 am. The other signatory was Barney Graham MD PhD, an investigator for the NIAID, however, this signature was not dated.

The final signatories on the agreement were Sunny Himansu, Moderna’s Investigator, and Shaun Ryan, Moderna’s Deputy General Councel. Both signautres were made on December 17th 2019

All of these signatures were made prior to any knowledge of the alleged emergence of the novel coronavirus. It wasn’t until December 31st 2019
that the World Health Organisation (WHO) became aware of an alleged
cluster of viral pneumonia cases in Wuhan, China.

Launched in 2009 and funded by USAID, PREDICT was an early warning system for new and emerging diseases in 21 countries. It was led by the University of California’s (“UC”) Davis One Health Institute and core partners included EcoHealth Alliance (“EHA”), Metabiota, Wildlife Conservation Society, and Smithsonian Institution, and as we’ve just revealed; Labyrinth Global Health. PREDICT was a forerunner of the more ambitious Global Virome Project.

The USAID describes PREDICT as having made “significant contributions to strengthening global surveillance and laboratory diagnostic capabilities for both known and newly discovered viruses within several important virus groups, such as filoviruses (including ebolaviruses), influenza viruses, paramyxoviruses, and coronaviruses“.

United States Government data show that the U.S. Department of Defense (DOD) awarded a contract on the 12th November 2019 to Labyrinth Global Health INC. for ‘COVID-19 Research’, at least one month before the alleged emergence of the novel coronavirus, and three months before it was officially dubbed Covid-19?

The shocking findings, however, do not end there. The contract awarded in November 2019 for ‘COVID-19 Research’ was not only instructed to take place in Ukraine, it was in fact part of a much larger contract for a ‘Biological threat reduction program in Ukraine’.

Perhaps explaining why Labyrinth Global Health has been collaborating with Peter Daszak’s EcoHealth Alliance, and Ernest Wolfe’s Metabiota
since its formation in 2017.

Award Search’ are details on a contract awarded by the Department of Defense to a company named ‘Black & Veatch Special Projects Corp‘, which is allegedly “a global engineering, procurement, consulting and construction company specialising in infrastructure development”.

The contract was awarded on September 20th, 2012 and is described as “Professional, Scientific, and Technical Services”. Obviously, this is very vague and most likely of little interest to anyone who happens to stumble across it. But there is something contained deep within the
details that should be of interest to anyone and everyone.

The ‘Award History’ for the contract contains a tab for ‘Sub-Awards’ detailing the recipients, action date, amount, and a very brief description for 115 Sub-Award transactions. Most of the Sub-Awards are extremely mundane for things such as “laboratory equipment for Kyiv”, or “office furniture for Kyiv”.

the Defense Threat Reduction Agency (DTRA). The contract was awarded 20th September 2012, and concluded on 13th October 2020.
https://expose-news.com/2022/05/18/us-dod-covid-research-contract-nov-2019/

2011 a virologist named Nathan Wolfe writes a book called
"The Viral Storm: The Dawn of a New Pandemic Age"
Of the ~16 friends Wolfe thanks for adding time/unique skills to this book we find:
- Jeffrey Epstein
- Boris Nikolic

Covid-19 and Ukrainian BioLabs
What are the odds?
Hunter Biden introduced Metabiota to an allegedly corrupt Ukrainian gas firm, Burisma, for a '
science project' and Metabiota detected Covid a week before the WHO in Dec 2019
https://www.dailymail.co.uk/news/article-10652127/Hunter-Biden-helped-secure-millions-funding-military-biotech-research-program-Ukraine.html

RELEASE OF PFIZER DOCUMENTS
A death rate however of 3% overall has been calculated, extrapolating out from these figures, and giving a generous margin of error in Pfizers favour.
https://lawyersforjusticeireland.wordpress.com/2022/03/20/release-of-pfizer-documents/

Did virus hunters cover up a lab leak?
They were set up to stop a pandemic — then disappeared
The seeds of the project were sown between 2009 and 2019, when the US government funded a big push into virus hunting in wildlife in
tropical regions through a programme called PREDICT. When this funding came to an end, the main players got together to seek private and charitable
funding to continue the work. These included, from government, Dennis Carrol, director of the Emerging Pandemic Threats Division within the
United States Agency for International Development; from academia, Jonna Mazet of the University of California at Davis, who had been
director of the PREDICT project; from the non-profit world, Peter Daszak, head of the EcoHealth Alliance, who became treasurer of the new
project; and from the private sector, Nathan Wolfe, founder of the DNA database firm Metabiota.

in March 2018, the EcoHealth Alliance, WIV and others had submitted a joint proposal to DARPA, the Pentagon’s research funding agency. It
included a section in which the researchers detailed plans to introduce a genetic sequence called a furin cleavage site into novel SARS-like
viruses to increase their ability to infect cells in the laboratory and make them easier to grow. This is the very sequence that has turned up in
the virus causing Covid, and in no other SARS-like coronavirus.

The proposal, titled DEFUSE, was turned down by DARPA. Shortly after, however, a “Special Project” was initiated by the CAS with Shi Zhengli
in charge for one of the subprojects. The scope largely corresponds and overlaps with the GVP and Project DEFUSE
https://unherd.com/2022/04/did-virus-hunters-cover-up-a-lab-leak/

Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
mRNA vaccines promote sustained synthesis of the SARS-CoV-2 spike protein.
The spike protein is neurotoxic, and it impairs DNA repair mechanisms.
Suppression of type I interferon responses results in impaired innate immunity.
The mRNA vaccines potentially cause increased risk to infectious diseases and cancer.
SARS-CoV-2 spike glycoprotein has prion-like characteristics (Tetz and Tetz, 2022).
https://www.sciencedirect.com/science/article/pii/S027869152200206X?

A third messenger RNA (mRNA) vaccine appears - new vaccine is a “self-amplifying” design allows for smaller doses.

Arcturus Therapeutics of San Diego, which staged a placebo-controlled trial of its candidate in more than 17,000 participants in Vietnam, announced yesterday in a press release that the vaccine had 55% efficacy against symptomatic COVID-19 and provided 95% efficacy against severe illness and death. “It’s a huge accomplishment that for the first time a self-amplifying RNA vaccine has been shown to be safe and effective,”

Arcturus’s success may also help make mRNA vaccines more broadly accessible. Its candidate incorporates a freeze-drying process to transform the mRNA-filled solution into a powder that can be stored at room temperature, then rehydrated.
https://www.science.org/content/article/mrna-vaccine-twist-it-copies-itself-protects-against-covid-19

"2019 Novel Coronavirus Vaccine" dated July 23 2019?
Making a vaccine 6 months before the pathogen officially appeared?

He referred to an interesting promotional B-roll video posted by NIH on Jan 30, 2020 about scientists working tirelessly to invent vaccine against “Novel Coronavirus”.

https://www.flickr.com/photos/niaid/49465177603/

This video shows, at about 1:00 minute mark, a woman taking out from a freezer, and placing back, a box with vials labeled “KC 2019 Novel Coronavirus Vaccine”.

What? How can the “2019 Novel Coronavirus Vaccine” be dated 7/23/2019, when “Novel Coronavirus” Sars-Cov-2 was only “discovered” in December 2019?

mRNA Coronavirus Vaccine Candidated Transferred from NIAID to Ralph Baric of UNC on Dec 16 2019:

These scientists seem to have worked very tirelessly PRIOR to the discovery of Sars-Cov-2, but knew a little bit too much about what ended up happening, PRIOR to the discovery. Here we see the Moderna vaccine candidate transferred from NIAID to Ralph Baric of UNC as of Dec 12, 2019:

Ralph Baric is the scientist who experimented with adding HIV genetic sequences to coronaviruses to enhance their function:
https://igorchudov.substack.com/p/2019-novel-coronavirus-vaccine-dated

~ClassWar ~AntiWar ~ BDS ~ Covid1984 @hatethemachine